Research Articles | Page 87 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms Jul 2019 Surgical Pathology Clinic myelodysplastic syndromes (MDS)
Defeating anaemia in myelodysplastic syndromes: another step forward Sep 2017 Lancet Oncol myelodysplastic syndromes (MDS)
Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria Sep 2014 J Clin Invest paroxysmal nocturnal hemoglobinuria (PNH)
Decreased plasma cytokines associate with low platelet counts in aplastic anemia and immune thrombocytopenic purpura Apr 2012 J Thromb Haemost
Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate Jan 2017 Expert Rev Hematol myelodysplastic syndromes (MDS)
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study Oct 2023 Leukemia aplastic anemia
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study Dec 2023 Leukemia aplastic anemia
Deacetylase Inhibitors for the Treatment of Myelodysplastic Syndromes Jul 2014 Leuk Lymphoma myelodysplastic syndromes (MDS)
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes Jan 2021 American Journal of Hematology myelodysplastic syndromes (MDS)
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.